First American Trust FSB Decreases Stake in Cigna Group $CI

First American Trust FSB lowered its position in shares of Cigna Group (NYSE:CI) by 9.4% in the fourth quarter, Holdings Channel reports. The firm owned 17,922 shares of the health services provider’s stock after selling 1,865 shares during the period. First American Trust FSB’s holdings in Cigna Group were worth $4,932,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Cary Street Partners Investment Advisory LLC grew its holdings in shares of Cigna Group by 11.0% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock worth $100,000 after purchasing an additional 36 shares during the period. OLD National Bancorp IN grew its holdings in shares of Cigna Group by 3.7% during the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after purchasing an additional 37 shares during the period. CYBER HORNET ETFs LLC grew its holdings in shares of Cigna Group by 5.3% during the 4th quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock worth $220,000 after purchasing an additional 40 shares during the period. BNP Paribas grew its holdings in shares of Cigna Group by 0.7% during the 4th quarter. BNP Paribas now owns 5,676 shares of the health services provider’s stock worth $1,566,000 after purchasing an additional 40 shares during the period. Finally, Cookson Peirce & Co. Inc. grew its holdings in shares of Cigna Group by 0.8% during the 3rd quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock worth $1,428,000 after purchasing an additional 41 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of CI opened at $296.34 on Thursday. The business’s 50 day moving average is $281.36 and its two-hundred day moving average is $277.76. Cigna Group has a 52-week low of $239.51 and a 52-week high of $338.89. The firm has a market cap of $78.39 billion, a price-to-earnings ratio of 12.56, a PEG ratio of 1.14 and a beta of 0.28. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. During the same period in the prior year, the company posted $6.74 EPS. Cigna Group’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.

Wall Street Analysts Forecast Growth

CI has been the subject of a number of research reports. Royal Bank Of Canada boosted their target price on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a report on Friday, May 1st. Robert W. Baird set a $337.00 target price on Cigna Group in a report on Friday, May 1st. Raymond James Financial set a $340.00 target price on Cigna Group in a report on Friday, May 1st. The Goldman Sachs Group upped their price target on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Cantor Fitzgerald upped their price target on Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $338.80.

Insider Activity

In related news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.